Your browser doesn't support javascript.
loading
Flap adhesion and effect on postoperative complication rates using Tissuglu® in mastectomy patients.
Eichler, Christian; Fischer, Petra; Sauerwald, Axel; Dahdouh, Faten; Warm, Mathias.
Afiliação
  • Eichler C; Department of Gynecology and Obstetrics, Holweide Hospital, Cologne, Germany. ceichler@gmail.com.
  • Fischer P; Brustzentrum, Krankenhaus Holweide, Neufelder Strasse 32, 51067, Köln, Germany. ceichler@gmail.com.
  • Sauerwald A; Department of Gynecology and Obstetrics, Holweide Hospital, Cologne, Germany.
  • Dahdouh F; Department of Gynecology and Obstetrics, Hospital Düren GmbH, Düren, Germany.
  • Warm M; Brustzentrum, Krankenhaus Holweide, Neufelder Strasse 32, 51067, Köln, Germany.
Breast Cancer ; 23(3): 486-90, 2016 May.
Article em En | MEDLINE | ID: mdl-25874687
ABSTRACT

INTRODUCTION:

Post-mastectomy seroma and related complications are common problems in modern oncological surgery. Occurrence rates of up to 59% have been reported in literature. High-risk patients, that is, those who have undergone previous surgeries, present with a high body mass index, have had radiation or chemotherapy, present a particular challenge. Noninvasive measures such as fibrin-based sealants have thus far not been able to effectively reduce complications associated with fluid accumulation. A recent study using a lysine-derived urethane adhesive named TissuGlu® however, showed promising results in patients after abdominoplasty.

METHODS:

32 consecutively recruited patients received a mastectomy using a gold standard mastectomy technique as well as TissuGlu® flap fixation. A control group of 173 patients, having received a gold standard mastectomy-only, was analyzed retrospectively, totaling 205 patients. Primary endpoints were post-discharge seroma formation and revision surgery/re-hospitalization. Secondary endpoints were initial seroma volume, postoperative pain, hematoma formation and day of drain removal.

RESULTS:

No significant difference in seroma formation was demonstrated. The revision surgery/re-hospitalization rate was reduced from 6.9 to 0%, though this did not reach significance. Significant improvement could be shown in the TissuGlu® group regarding time to drain removal (17% decrease), and hematoma formation (14% decrease). No difference was shown in postoperative pain.

CONCLUSION:

Although patient numbers are still small, advantages in revision surgery/re-hospitalization rate, hematoma formation as well as time to drain removal was shown for the TissuGlu® group. CLINICAL QUESTION/LEVEL OF EVIDENCE Therapeutic, IV.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Retalhos Cirúrgicos / Neoplasias da Mama / Mastectomia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Retalhos Cirúrgicos / Neoplasias da Mama / Mastectomia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article